A four-biomarker blood signature discriminates systemic inflammation due to viral infection versus other etiologies

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Sampson, D L ^a   Fox, B A ^a   Yager, T D ^a   Bhide, S ^a   Cermelli, S ^a   McHugh, L C ^a   Seldon, T A ^a   Brandon, R A ^a   Sullivan, E ^b   Zimmerman, J J ^b,c   Noursadeghi, M ^d,e   Brandon, R B ^a  

^a Immunexpress   (United States)

^b SEATTLE CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; TRANSCRIPTOME;

ADOLESCENT; BLOOD; CASE CONTROL STUDY; CHILD; FACTUAL DATABASE; FEMALE; GENE EXPRESSION PROFILING; GENETICS; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; INFANT; INFLAMMATION; MALE; PRESCHOOL CHILD; REPRODUCIBILITY; VIROLOGY; VIRUS INFECTION;

ADOLESCENT; BIOMARKERS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; FEMALE; GENE EXPRESSION PROFILING; HOST-PATHOGEN INTERACTIONS; HUMANS; INFANT; INFLAMMATION; MALE; REPRODUCIBILITY OF RESULTS; TRANSCRIPTOME; VIRUS DISEASES;

EID: 85020425486     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-02325-8     Document Type: Article

References (121)

1. Comstedt, P., Storgaard, M., & Lassen, A. T. The Systemic Inflammatory Response Syndrome (SIRS) in acutely hospitalised medical patients: a cohort study. Scand. J. Trauma Resusc. Emerg. Med. 17, 67-72, doi: 10.1186/1757-7241-17-67 (2009
2. Pavare, J., Grope, I., & Gardovska, D. Prevalence of systemic inflammatory response syndrome (SIRS) in hospitalized children: a point prevalence study. BMC Pediatr. 9, 25-30, doi: 10.1186/1471-2431-9-25 (2009
3. Munro, N. Fever in acute and critical care: a diagnostic approach. AACN Adv. Crit. Care 25, 237-248, doi: 10.1097/NCI.0000000000000041 (2014
4. Niska, R., Bhuiya, F., & Xu, J. National hospital ambulatory medical care survey: 2007 emergency department summary. Natl. Health Stat. Report 26, 1-31, https://www.cdc.gov/nchs/data/nhsr/nhsr026.pdf (2010
5. Braykov, N. P., et al. Assessment of empirical antibiotic therapy optimisation in six hospitals: an observational cohort study. The Lancet Infectious Diseases 14, 1220-1227, doi: 10.1016/S1473-3099(14)70952-1 (2014
6. Coburn, B., Morris, A. M., Tomlinson, G., & Detsky, A. S. Does this adult patient with suspected bacteremia require blood cultures? JAMA 308, 502-511, doi: 10.1001/jama.2012.8262 (2012
7. Centers for Disease Control and Prevention (CDC). Antibiotic resistance threats in the United States, 2013. Atlanta: CDC. http://www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013-508.pdf (2013
8. Hament, J. M., Kimpen, J. L., Fleer, A., & Wolfs, T. F. Respiratory viral infection predisposing for bacterial disease: a concise review. FEMS Immunol. Med. Microbiol. 26, 189-195, doi: 10.1111/j.1574-695X.1999.tb01389.x (1999
9. Zaas, A. K., et al. Gene expression signatures diagnose influenza and other symptomatic respiratory viral infections in humans. Cell Host, & Microbe 6, 207-217, doi: 10.1016/j.chom.2009.07.006 (2009
10. Zhai, Y., et al. Host transcriptional response to influenza and other acute respiratory viral infections - a prospective cohort study. PLOS Pathog. 11, e1004869-29, doi: 10.1371/journal.ppat.1004869 (2015
11. Storch, G. A. Diagnostic virology. Clin. Infect. Dis. 31, 739-751, doi: 10.1086/314015 (2000
12. Cobo, F. Application of molecular diagnostic techniques for viral testing. Open Virol. J. 6, 104-114, doi: 10.2174/1874357901206010104 (2012
13. Jansen, R. R., et al. Frequent detection of respiratory viruses without symptoms: toward defining clinically relevant cutoff values. J. Clin. Microbiol. 49, 2631-2636, doi: 10.1128/JCM.02094-10 (2011
14. Yu, C., et al. Pathogenesis of hepatitis E virus and hepatitis C virus in chimpanzees: similarities and differences. J. Virol. 84, 11264-11278, doi: 10.1128/JVI.01205-10 (2010
15. Huang, Y., et al. Temporal Dynamics of Host Molecular Responses Differentiate Symptomatic and Asymptomatic Influenza A Infection. PLOS Genet. 7, e1002234-17, doi: 10.1371/journal.pgen.1002234 (2011
16. Parnell, G. P., et al. A distinct influenza infection signature in the blood transcriptome of patients with severe community-acquired pneumonia. Crit. Care 16, R157, doi: 10.1186/cc11477 (2012
17. Hu, X., Yu, J., Crosby, S. D., & Storch, G. A. Gene expression profiles in febrile children with defined viral and bacterial infection. Proc. Natl. Acad. Sci. USA 110, 12792-12797, doi: 10.1073/pnas.1302968110 (2013
18. Woods, C. W., et al. A host transcriptional signature for presymptomatic detection of infection in humans exposed to influenza H1N1 or H3N2. PLOS ONE 8, e52198, doi: 10.1371/journal.pone.0052198 (2013
19. Zaas, A. K., et al. A host-based RT-PCR gene expression signature to identify acute respiratory viral infection. Sci. Transl. Med. 5, 203ra126-203ra126, doi: 10.1126/scitranslmed.3006280 (2013
20. Andres-Terre, M., et al. Integrated, multi-cohort analysis identifies conserved transcriptional signatures across multiple respiratory viruses. Immunity 43, 1199-1211, doi: 10.1016/j.immuni.2015.11.003 (2015
21. Heinonen, S., et al. Rhinovirus detection in symptomatic and asymptomatic children: value of host transcriptome analysis. Am. J. Respir. Crit. Care Med. 193, 772-782, doi: 10.1164/rccm.201504-0749OC (2016
22. Sweeney, T. E., Wong, H. R., & Khatri, P. Robust classification of bacterial and viral infections via integrated host gene expression diagnostics. Sci. Transl. Med. 8, 346ra91-346ra91, doi: 10.1126/scitranslmed.aaf7165 (2016
23. Herberg, J. A., et al. Diagnostic test accuracy of a 2-transcript host RNA signature for discriminating bacterial vs viral infection in febrile children. JAMA 316, 835-845, doi: 10.1001/jama.2016.11236 (2016
24. Robinson, C., & Echavarria, M. Adenoviruses In Manual of Clinical Microbiology, 9th edition (ed. Murray, P.R., et al.) 1589 (ASM Press, 2007
25. Wold, W. S. M., & Horwitz, M. S. Adenoviruses In Fields Virology, 5th edition (eds. Knipe D. M., & Howley, P. M.) 2395-2436 (Lippincott Williams, & Wilkins, 2007
26. Lenaerts, L., De Clercq, E., & Naesens, L. Clinical features and treatment of adenovirus infections. Revs. Med. Virol. 18, 357-374, doi: 10.1002/rmv.589 (2008
27. Flomenberg, P. Adenovirus infections. Medicine 37, 676-678, doi: 10.1016/j.mpmed.2009.09.003 (2009
28. Kiang, A., et al. Multiple innate inflammatory responses induced after systemic adenovirus vector delivery depend on a functional complement system. Mol. Ther. 14, 588-598, doi: 10.1016/j.ymthe.2006.03.024 (2006
29. Eskildsen, S., Justesen, J., Schierup, M. H., & Hartmann, R. Characterization of the 2′-5′-oligoadenylate synthetase ubiquitin-like family. Nucleic Acids Res. 31, 3166-3173 (2003
30. Tomas, A., Fernandes, L. T., Sanchez, A., & Segales, J. Time course differential gene expression in response to porcine circovirus type 2 subclinical infection. Vet. Res. 41, 12-27, doi: 10.1051/vetres/2009060 (2012
31. Yen, C., et al. Rotavirus vaccines. Human Vaccines 7, 1282-1290, doi: 10.4161/hv.7.12.18321 (2014
32. Tsuge, M., et al. Gene expression analysis in children with complex seizures due to influenza A(H1N1)pdm09 or rotavirus gastroenteritis. J. Neurovirol. 20, 73-84, doi: 10.1007/s13365-013-0231-5 (2014
33. Daep, C. A., Muñoz-Jordán, J. L., & Eugenin, E. A. Flaviviruses, an expanding threat in public health: focus on dengue, West Nile, and Japanese encephalitis virus. J. Neurovirol. 20, 539-560, doi: 10.1007/s13365-014-0285-z (2014
34. Garske, T., et al. Yellow fever in Africa: estimating the burden of disease and impact of mass vaccination from outbreak and serological data. PLOS Med. 11, e1001638-17, doi: 10.1371/journal.pmed.1001638 (2014
35. Gaucher, D., et al. Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J. Exp. Med. 205, 3119-3131, doi: 10.1084/jem.20082292 (2008
36. Nair, H., et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 375, 1545-1555, doi: 10.1016/S0140-6736(10)60206-1 (2010
37. Brand, H. K., et al. Olfactomedin 4 serves as a marker for disease severity in pediatric respiratory syncytial virus (RSV) infection. PLOS ONE 10, e0131927-14, doi: 10.1371/journal.pone.0131927 (2015
38. Skinner, J., et al. P01-01. The blood transcriptional response to early acute HIV infection is transient and responsive to antiretroviral therapy. Retrovirology 6(Suppl. 3), P1, doi: 10.1186/1742-4690-6-S3-P1 (2009
39. Lamontagne, J., Mell, J. C., Bouchard, M. J., & Siddiqui, A. Transcriptome-wide analysis of hepatitis B virus-mediated changes to normal hepatocyte gene expression. PLOS Pathog. 12, e1005438-35, doi: 10.1371/journal.ppat.1005438 (2016
40. Zimmerman, J. J., et al. Diagnostic accuracy of a host gene expression signature that discriminates clinical severe sepsis syndrome and infection-negative systemic inflammation among critically ill children. Crit. Care. Med. 45, e418-e425, doi: 10.1097/CCM.0000000000002100 (2017
41. McHugh, L., et al. A molecular host response assay to discriminate between sepsis and infection-negative systemic inflammation in critically ill patients: discovery and validation in independent cohorts. PLOS Med. 12, e1001916-35, doi: 10.1371/journal. pmed.1001916 (2015
42. Tsalik, E. L., et al. Host gene expression classifiers diagnose acute respiratory illness etiology. Sci. Transl. Med. 8, 322ra11-322ra11, doi: 10.1126/scitranslmed.aad6873 (2016
43. Breiman, L. Random forests. Mach. Learn. 45, 5-32, doi: 10.1023/A: 1010933404324 (2001
44. Mardia, K. V. Some properties of classical multidimensional scaling. Commun. Stat. Theory Methods A 7, 1233-1241, doi: 10.1080/03610927808827707 (1978
45. Cox, T. F., & Cox, M. A. A. Multidimensional Scaling, 2nd edition (Chapman and Hall, 2001
46. Li, J., et al. Identification of high-quality cancer prognostic markers and metastasis network modules. Nat. Commun. 1, 34, doi: 10.1038/ncomms1033 (2010
47. Brennan, K., & Bowie, A. G. Activation of host pattern recognition receptors by viruses. Curr. Opin. Microbiol. 13, 503-507, doi: 10.1016/j.mib.2010.05.007 (2010
48. Thompson, M. R., Kaminski, J. J., Kurt-Jones, E. A., & Fitzgerald, K. A. Pattern recognition receptors and the innate immune response to viral infection. Viruses 3, 920-940, doi: 10.3390/v3060920 (2011
49. Ritchie, K. J., et al. Role of ISG15 protease UBP43 (USP18) in innate immunity to viral infection. Nat. Med. 10, 1374-1378, doi: 10.1038/nm1133 (2004
50. Malakhova, O. A., & Zhang, D. E. ISG15 inhibits Nedd4 ubiquitin E3 activity and enhances the innate antiviral response. J. Biol. Chem. 283, 8783-8787, doi: 10.1074/jbc.C800030200 (2008
51. Chen, L., Li, S., & McGilvray, I. The ISG15/USP18 ubiquitin-like pathway (ISGylation system) in hepatitis C virus infection and resistance to interferon therapy. Int. J. Biochem. Cell Biol. 43, 1427-1431, doi: 10.1016/j.biocel.2011.06.006 (2011
52. Zhang, X., et al. Human intracellular ISG15 prevents interferon-α/β over-amplification and auto-inflammation. Nature 517, 89-93, doi: 10.1038/nature13801 (2014
53. Choi, U. Y., Kang, J.-S., Hwang, Y. S., & Kim, Y.-J. Oligoadenylate synthase-like (OASL) proteins: dual functions and associations with diseases. Exp. Mol. Med. 47, e144-6, doi: 10.1038/emm.2014.110 (2015
54. Schoggins, J. W., et al. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472, 481-485, doi: 10.1038/nature09907 (2011
55. Strouts, F. R., et al. Early transcriptional signatures of the immune response to a live attenuated tetravalent dengue vaccine candidate in non-human primates. PLOS Negl. Trop. Dis. 10, e0004731, doi: 10.1371/journal.pntd.0004731 (2016
56. Baier, M., Werner, A., Bannert, N., Metzner, K., & Kurth, R. HIV suppression by interleukin-16. Nature 378, 563-563, doi: 10.1038/378563a0 (1995
57. Truong, M. J., et al. Interleukin-16 inhibits human immunodeficiency virus type 1 entry and replication in macrophages and in dendritic cells. J Virol. 73, 7008-7013 (1999
58. Romani, S., et al. Interleukin-16 gene polymorphisms are considerable host genetic factors for patients? susceptibility to chronic hepatitis B infection. Hepat. Res. Treat. 2014, 790753-5, doi: 10.1155/2014/790753 (2014
59. Nimmanapalli, R., Sharmila, C., & Reddy, P. G. Immunomodulation of caprine lentiviral infection by interleukin-16. Comp. Immunol. Microbiol. Infect. Dis. 33, 529-536, doi: 10.1016/j.cimid.2009.09.003 (2010
60. Glass, W. G., Sarisky, R. T., & Vecchio, A. M. Not-so-sweet sixteen: the role of IL-16 in infectious and immune-mediated inflammatory diseases. J. Interferon Cytokine Res. 26, 511-520, doi: 10.1089/jir.2006.26.511 (2006
61. Bowler, R. P., et al. Integrative omics approach identifies interleukin-16 as a biomarker of emphysema. OMICS 17, 619-626, doi: 10.1089/omi.2013.0038 (2013
62. Ludwiczek, O., et al. Activation of caspase-3 by interferon alpha causes interleukin-16 secretion but fails to modulate activation induced cell death. Eur. Cytokine Netw. 12, 478-486 (2001
63. Nischwitz, S., et al. Interferon β-1a reduces increased interleukin-16 levels in multiple sclerosis patients. Acta. Neurol. Scand. 130, 46-52, doi: 10.1111/ane.12215 (2014
64. Santin, A. D., et al. Gene expression profiles of primary HPV16-and HPV18-infected early stage cervical cancers and normal cervical epithelium: identification of novel candidate molecular markers for cervical cancer diagnosis and therapy. Virology 331, 269-291, doi: 10.1016/j.virol.2004.09.045 (2005
65. Zhou, H., et al. Genome-scale RNAi screen for host factors required for HIV replication. Cell Host Microbe 4, 495-504, doi: 10.1016/j.chom.2008.10.004 (2008
66. Sobo, K., Rubbia-Brandt, L., Brown, T. D., Stuart, A. D., & McKee, T. A. Decay-accelerating factor binding determines the entry route of echovirus 11 in polarized epithelial cells. J. Virol. 85, 12376-12386, doi: 10.1128/JVI.00016-11 (2011
67. Plevka, P., et al. Interaction of decay-accelerating factor with echovirus 7. J. Virol. 84, 12665-12674, doi: 10.1128/JVI.00837-10 (2010
68. S. Hafenstein, S., et al. Interaction of decay-accelerating factor with coxsackievirus B3. J. Virol. 81, 12927-12935, doi: 10.1128/JVI.00931-07 (2007
69. Yoder, J. D., Cifuente, J. O., Pan, J., Bergelson, J. M., & Hafenstein, S. The crystal structure of a coxsackievirus B3-RD variant and a refined 9-angstrom cryo-electron microscopy reconstruction of the virus complexed with decay-accelerating factor (DAF) provide a new footprint of DAF on the virus surface. J Virol. 86, 12571-12581, doi: 10.1128/JVI.01592-12 (2012
70. Ramilo, O., et al. Gene expression patterns in blood leukocytes discriminate patients with acute infections. Blood 109, 2066-2077, doi: 10.1182/blood-2006-02-002477 (2007
71. Sweeney, T. E., Shidham, A., Wong, H. R., & Khatri, P. A comprehensive time-course-based multicohort analysis of sepsis and sterile inflammation reveals a robust diagnostic gene set. Sci Transl. Med. 7, 287ra71-287ra71, doi: 10.1126/scitranslmed.aaa5993 (2015
72. Han, J. H., et al. Use of a combination biomarker algorithm to identify medical intensive care unit patients with suspected sepsis at very low likelihood of bacterial infection. Antimicrob. Agents Chemother. 59, 6494-500, doi: 10.1128/AAC.00958-15 (2015
73. Venkatraman, E. S. A permutation test to compare receiver operating characteristic curves. Biometrics 56, 1134-1138, doi: 10.1111/j.0006-341X.2000.01134.x (2000
74. Hanley, J. A., & McNeil, B. J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiol. 143, 29-36, doi: 10.1148/radiology.143.1.7063747 (1982
75. De Winter, J. C. F. Using the Student?s t-test with extremely small sample sizes. Pract. Assess. Res. Eval. 18, 1-12 (2013
76. Raghavachari, N., et al. A systematic comparison and evaluation of high density exon arrays and RNA-seq technology used to unravel the peripheral blood transcriptome of sickle cell disease. BMC Med. Genomics 5, 28, doi: 10.1186/1755-8794-5-28 (2012
77. Zhao, S., Fung-Leung, W. P., Bittner, A., Ngo, K., & Liu, X. Comparison of RNA-seq and microarray in transcriptome profiling of activated T cells. PLOS One 9, e78644, doi: 10.1371/journal.pone.0078644 (2014
78. Lê Cao, K. A., Rohart, F., McHugh, L., Korn, O., & Wells, C. A. YuGene: a simple approach to scale gene expression data derived from different platforms for integrated analyses. Genomics 103, 239-251, doi: 10.1016/j.ygeno.2014.03.001 (2014
79. W. Zhang, W., et al. Comparison of RNA-seq and microarray-based models for clinical endpoint prediction. Genome Biol. 16, 133, doi: 10.1186/s13059-015-0694-1 (2015
80. F. F. Millenaar, F. F., et al. How to decide? Different methods of calculating gene expression from short oligonucleotide array data will give different results. BMC Bioinformatics 7, 137, doi: 10.1186/1471-2105-7-137 (2006
81. Jiang, N., et al. Methods for evaluating gene expression from Affymetrix microarray datasets. BMC Bioinformatics 9, 284, doi: 10.1186/1471-2105-9-284 (2008
82. Fonseca, N. A., Marioni, J., & Brazma, A. RNA-seq gene profiling -a systematic empirical comparison. PLOS One 9, e107026, doi: 10.1371/journal.pone.0107026 (2014
83. Williams, C. R., Baccarella, A., Parrish, J. Z., & Kim, C. C. Trimming of sequence reads alters RNA-seq gene expression estimates. BMC Bioinformatics 17, 103, doi: 10.1186/s12859-016-0956-2 (2016
84. Xu, J., et al. Comprehensive assessments of RNA-seq by the SEQC Consortium: FDA-led efforts advance precision medicine. Pharmaceutics 8, pii: E8, doi: 10.3390/pharmaceutics8010008 (2016
85. Macrae, B., & Nastouli, E. University College London Hospitals (UCHL) Virology User Manual version 16.0. Policy Unique Reference # 35-52429909. Authorization date 03-feb-2015. https://www.uclh.nhs.uk/OurServices/ServiceA-Z/PATH/PATHMICRO/VIRO/Documents/Virology-user-manual.pdf
86. Dillies, M. A., et al. A comprehensive evaluation of normalization methods for Illumina high-throughput RNA sequencing data analysis. Brief. Bioinform. 14, 671-683, doi: 10.1093/bib/bbs046 (2013
87. Ojala, M., & Garriga, G. C. Permutation Tests for Studying Classifier Performance. J. Mach. Learn. Res. 11, 1833-1863 (2010
88. Kuparinen, T., et al. Cytomegalovirus (CMV)-dependent and -independent changes in the aging of the human immune system: a transcriptomic analysis. Exp. Gerontol. 48, 305-312, doi: 10.1016/j.exger.2012.12.010 (2013
89. Kwissa, M., et al. Dengue virus infection induces expansion of a CD14(+)CD16(+) monocyte population that stimulates plasmablast differentiation. Cell Host, & Microbe 16, 115-127, doi: 10.1016/j.chom.2014.06.001 (2014
90. S. Malhotra, S., et al. Transcriptional profiling of the circulating immune response to Lassa virus in an aerosol model of exposure. PLOS Negl. Trop. Dis. 7, e2171-13, doi: 10.1371/journal.pntd.0002171 (2013
91. Nascimento, E. J. M., et al. Gene expression profiling during early acute febrile stage of dengue infection can predict the disease outcome. PLOS ONE 4, e7892, doi: 10.1371/journal.pone.0007892 (2009
92. Huang, Y., et al. Temporal dynamics of host molecular responses differentiate symptomatic and asymptomatic influenza a infection. PLOS Genet. 7, e1002234, doi: 10.1371/journal.pgen.1002234 (2011
93. Bolen, C. R., et al. The blood transcriptional signature of chronic hepatitis C virus is consistent with an ongoing interferon-mediated antiviral response. J. Interferon Cytokine Res. 33, 15-23, doi: 10.1089/jir.2012.0037 (2013
94. Djavani, M. M., et al. Early blood profiles of virus infection in a monkey model for Lassa fever. J. Virol. 81, 7960-7973, doi: 10.1128/JVI.00536-07 (2007
95. Ioannidis, I., et al. Plasticity and virus specificity of the airway epithelial cell immune response during respiratory virus infection. J. Virol. 86, 5422-5436, doi: 10.1128/JVI.06757-11 (2012
96. Zilliox, M. J., Moss, W. J., & Griffin, D. E. Gene expression changes in peripheral blood mononuclear cells during measles virus infection. Clin. Vaccine Immunol. 14, 918-923, doi: 10.1128/CVI.00031-07 (2007
97. Wang, Y., et al. Rotavirus infection alters peripheral T-cell homeostasis in children with acute diarrhea. J. Virol. 81, 3904-3912, doi: 10.1128/JVI.01887-06 (2007
98. Ahn, S. H., et al. Gene expression-based classifiers identify Staphylococcus aureus infection in mice and humans. PLOS ONE 8, e48979, doi: 10.1371/journal.pone.0048979 (2013
99. Bloom, C. I., et al. Transcriptional blood signatures distinguish pulmonary tuberculosis, pulmonary sarcoidosis, pneumonias and lung cancers. PLOS ONE 8, e70630, doi: 10.1371/journal.pone.0070630 (2013
100. Dickinson, P., et al. Whole blood gene expression profiling of neonates with confirmed bacterial sepsis. Genom. Data 3, 41-48, doi: 10.1016/j.gdata.2014.11.003 (2015
101. Banchereau, R., et al. Host immune transcriptional profiles reflect the variability in clinical disease manifestations in patients with Staphylococcus aureus infections. PLoS ONE 7, e34390-11, doi: 10.1371/journal.pone.0034390 (2012
102. Lee, H. M., Sugino, H., Aoki, C., & Nishimoto, N. Underexpression of mitochondrial-DNA encoded ATP synthesis-related genes and DNA repair genes in systemic lupus erythematosus. Arthritis Res. Ther. 13, R63, doi: 10.1186/ar3317 (2011
103. Bjornsdottir, U. S., et al. Pathways activated during human asthma exacerbation as revealed by gene expression patterns in blood. PLOS ONE 6, e21902-19, doi: 10.1371/journal.pone.0021902 (2011
104. De Jong, S., et al. A gene co-expression network in whole blood of schizophrenia patients is independent of antipsychotic-use and enriched for brain-expressed genes. PLOS ONE 7, e39498-10, doi: 10.1371/journal.pone.0039498 (2012
105. Xiao, W., et al. A genomic storm in critically injured humans. J. Exp. Med. 208, 2581-2590, doi: 10.1084/jem.20111354 (2011
106. Wingo, A. P., & Gibson, G. Blood gene expression profiles suggest altered immune function associated with symptoms of generalized anxiety disorder. Brain Behav. Immun. 43, 184-191, doi: 10.1016/j.bbi.2014.09.016 (2015
107. Ardura, M. I., et al. Enhanced monocyte response and decreased central memory T cells in children with invasive Staphylococcus aureus infections. PLOS ONE 4, e5446-17, doi: 10.1371/journal.pone.0005446 (2009
108. Preininger, M., et al. Blood-informative transcripts define nine common axes of peripheral blood gene expression. PLOS Genet. 9, e1003362-13, doi: 10.1371/journal.pgen.1003362 (2013
109. Bogunovic, D., et al. Mycobacterial disease and impaired IFN-γ immunity in humans with inherited ISG15 deficiency. Science 337, 1684-1688, doi: 10.1126/science.1224026 (2012
110. X. Zhang, X., et al. Human intracellular ISG15 prevents interferon-α/β over-amplification and auto-inflammation. Nature 517, 89-93, doi: 10.1038/nature13801 (2015
111. Okumura, A., Lu, G., Pitha-Rowe, I., & Pitha, P. M. Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15. Proc. Natl. Acad. Sci. USA. 103, 1440-1445, doi: 10.1073/pnas.0510518103 (2006
112. Okumura, A., Pitha, P. M., & Harty, R. N. ISG15 inhibits Ebola VP40 VLP budding in an L-domain-dependent manner by blocking Nedd4 ligase activity. Proc. Natl. Acad. Sci. USA 105, 3974-3979, doi: 10.1073/pnas.0710629105 (2008
113. Zhou, P., Goldstein, S., Devadas, K., Tewari, D., & Notkins, A. L. Human CD4+ cells transfected with IL-16 cDNA are resistant to HIV-1 infection: inhibition of mRNA expression. Nat. Med. 3, 659-664, doi: 10.1038/nm0697-659 (1997
114. Zhou, P., Devadas, K., Tewari, D., Jegorow, A., & Notkins, A. L. Processing, secretion, and anti-HIV-1 activity of IL-16 with or without a signal peptide in CD4+ T cells. J. Immunol. 163, 906-912 (1999
115. Zhu, J., et al. Antiviral activity of human OASL protein is mediated by enhancing signaling of the RIG-I RNA sensor. Immunity 40, 936-948, doi: 10.1016/j.immuni.2014.05.007 (2014
116. Alcorn, J. F., & Sarkar, S. N. What is the oligoadenylate synthetases-like protein and does it have therapeutic potential for influenza? Expert Rev. Respir. Med. 9, 1-3, doi: 10.1586/17476348.2015.994608 (2014
117. Gray, J. X., et al. CD97 is a processed, seven-transmembrane, heterodimeric receptor associated with inflammation. J. Immunol. 157, 5438-5447 (1996
118. Leemans, J. C., et al. The epidermal growth factor-seven transmembrane (EGF-TM7) receptor CD97 is required for neutrophil migration and host defense. J. Immunol. 172, 1125-1131, doi: 10.4049/jimmunol.172.2.1125 (2004
119. Qiu, X., et al. Diversity in compartmental dynamics of gene regulatory networks: the immune response in primary influenza A infection in mice. PLOS One 10, e0138110, doi: 10.1371/journal.pone.0138110 (2015
120. Connor, J. H., et al. Transcriptional profiling of the immune response to Marburg virus infection. J. Virol. 89, 9865-9874, doi: 10.1128/JVI.01142-15 (2015
121. Lin, K. L., et al. Temporal characterization of Marburg virus Angola infection following aerosol challenge in rhesus macaques. J. Virol. 89, 9875-9885, doi: 10.1128/JVI.01147-15 (2015